Arthur A. Vandenbark
Corporate Officer/Principal en Artielle ImmunoTherapeutics, Inc. .
Perfil
Arthur A.
Vandenbark is the founder of Artielle ImmunoTherapeutics, Inc. which was founded in 2004.
He held the title of Scientist at the time of founding.
Currently, he holds the title of Professor at Oregon Health & Science University Foundation.
Cargos activos de Arthur A. Vandenbark
| Empresas | Cargo | Inicio |
|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/2004 |
Oregon Health & Science University Foundation
 Oregon Health & Science University Foundation Miscellaneous Commercial ServicesCommercial Services Oregon Health & Science University Foundation exists to secure private philanthropic support for Oregon Health & Science University. The organization also invests and manages gifts from different donors. The OHSU Foundation also administers a separate grant-making program, the Medical Research Foundation awards, supporting biomedical research in Oregon by new investigators. It was founded in 1887 and is headquartered in Portland, OR. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
Oregon Health & Science University Foundation
Oregon Health & Science University Foundation Miscellaneous Commercial ServicesCommercial Services Oregon Health & Science University Foundation exists to secure private philanthropic support for Oregon Health & Science University. The organization also invests and manages gifts from different donors. The OHSU Foundation also administers a separate grant-making program, the Medical Research Foundation awards, supporting biomedical research in Oregon by new investigators. It was founded in 1887 and is headquartered in Portland, OR. | Commercial Services |
- Bolsa de valores
- Insiders
- Arthur A. Vandenbark
